Stock Earnings

Question 1

Ernexa Therapeutics Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Ernexa Therapeutics Inc'in toplam varlıkları $5 olup, net loss $-44'dir.

Question 2

ERNA'ün temel finansal oranları nelerdir?

Accepted Answer

Ernexa Therapeutics Inc'in cari oranı 1.66, net kâr marjı 0, hisse başına satış $0'dir.

Question 3

Ernexa Therapeutics Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Ernexa Therapeutics Inc largest revenue segment is Cellular Therapies, at a revenue of 582,000 in the most earnings release.For geography, United States is the primary market for Ernexa Therapeutics Inc, at a revenue of 582,000.

Question 4

Ernexa Therapeutics Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Ernexa Therapeutics Inc'in net loss $-44'dir.

Question 5

Ernexa Therapeutics Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Ernexa Therapeutics Inc'in yükümlülüğü 3'dir.

Question 6

Ernexa Therapeutics Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Ernexa Therapeutics Inc'in toplam tedavüldeki hisse sayısı 3.42'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	5
Revenue Growth (YoY)	--	--	--	--	-100%	-74%
Cost of Revenue	0	0	0	--	--	2
Gross Profit	0	0	0	--	--	2
Selling, General & Admin	7	13	14	16	14	6
Research & Development	4	4	5	10	12	2
Operating Expenses	33	17	20	27	27	8
Other Non Operating Income (Expenses)	-5	0	0	9	0	2
Pretax Income	-43	-44	-21	-24	-122	-4
Income Tax Expense	0	0	0	0	0	0
Net Income	-43	-44	-21	-24	-122	-4
Net Income Growth	87%	110%	-13%	-80%	2,950%	100%
Shares Outstanding (Diluted)	5.17	0.9	0.35	0.2	0.14	0
Shares Change (YoY)	1,336%	157%	74%	41%	2,847%	2%
EPS (Diluted)	-8.44	-48.97	-61.2	-120.94	-848.98	-907.78
EPS Growth	-87%	-20%	-49%	-86%	-6%	111%
Free Cash Flow	-14	-16	-20	-21	-23	-4
Free Cash Flow Per Share	-2.7	-17.58	-56.44	-103.24	-159.27	-816.32
Gross Margin	0%	0%	0%	--	--	40%
Operating Margin	0%	0%	0%	0%	0%	-100%
Profit Margin	0%	0%	0%	0%	0%	-80%
Free Cash Flow Margin	0%	0%	0%	0%	0%	-80%
EBITDA	-32	-17	-20	-27	-27	-4
EBITDA Margin	0%	0%	0%	0%	0%	-80%
D&A For EBITDA	0	0	0	0	0	1
EBIT	-32	-17	-20	-27	-27	-5
EBIT Margin	0%	0%	0%	0%	0%	-100%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Ernexa Therapeutics Inc (ERNA) Price

ERNA Stock Price Chart

ERNA Income

Follow-Up Questions